[PubMed] [Google Scholar] 69.Dietrich D.R., Heussner A.H., OBrien E
The mechanisms behind gallstone formation with GLP-1 agonists involve rapid weight loss and altered bile composition, both of which may be less pronounced at microdoses where weight loss is slower
*Correspondence: Mathias Hallberg, [email protected] This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Due to its role in sleep regulation and stable profile, DSIP is suitable for extended research where recovery, stress balance, and neurological support are key areas of interest
A 2014 publication (McCoy et al., Journal of Pharmacology and Experimental Therapeutics) was retracted due to concerns about data fabrication